Altus Research, Inc.

Lake Worth, Florida 33461

0 studies enrolling now · 15 studies all time

What they study most

Candida Vulvovaginitis, Candidiasis, Vulvovaginal, Contraception, Fatty Liver, Healthy, Lower Respiratory Tract Disease, Moniliasis, Vulvovaginal, Mycoses, Participants With or Without Stable Co-morbidities Associated With Progression to Severe COVID-19, Plaque Psoriasis, Pregnancy, Psoriasis

Studies at this site

• FemBloc® Permanent Contraception - Early Pivotal Trial — Completed
• Contraceptive Efficacy and Safety of NOMAC-E2 Combined Oral Contraceptive — Stopped early
• A Study of an Adenovirus Serotype 26 Pre-fusion Conformation-stabilized F Protein (Ad26. RSV. preF) Based Respiratory Syncytial Virus (RSV) Vaccine in the Prevention of Lower Respiratory Tract Disease in Adults Aged 60 Years and Older — Completed
• Evaluation of Efficacy, Safety and Tolerability of VeraCept IUS — Running, not enrolling
• A Study of Ad26.COV2.S for the Prevention of SARS-CoV-2-mediated COVID-19 in Adults — Completed
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis — Completed
• A Study to Investigate Interchangeability of ABP 654 for the Treatment of Participants With Moderate to Severe Plaque Psoriasis — Completed
• Pilot Bi-Lateral Tubal Occlusion Trial for Female Permanent Contraception — Completed
• Dose-Finding Study of Oral Ibrexafungep (SCY-078) vs. Oral Fluconazole in Subjects With Acute Vulvovaginal Candidiasis — Completed
• Study to Assess the Relationship Between Daily Dosing of NRPT and Changes in Liver Fat in Healthy Volunteers — Completed
• RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections — Completed
• Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization — Completed
• A Trial to Assess the Safety, Tolerability, and Immunogenicity of Bivalent rLP2086 Vaccine When Given to Healthy Young Adults Aged >=18 to <26 Years. — Completed
• Pharmacokinetic Study of Makena® (Hydroxyprogesterone Caproate Injection, 250 mg/mL) and Its Metabolites in Blood — Completed
• A Multicenter Study of NB-001 in the Treatment of Recurrent Herpes Labialis (SHaRCS) — Completed